| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 28, 2026 | ±2.5% | -3.5% | under-priced |
| October 28, 2025 | ±1.9% | +5.5% | under-priced |
| July 24, 2025 | ±1.9% | -0.8% | over-priced |
| April 29, 2025 | ±2.4% | +4.8% | under-priced |
| October 22, 2024 | ±1.4% | -5.3% | under-priced |
| July 23, 2024 | ±1.8% | +6.9% | under-priced |
| April 30, 2024 | ±2.4% | -2.1% | over-priced |
| October 24, 2023 | ±2.5% | -1.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.15 | $5.7B | $535M |
| Q4 FY2025 | $1.92 | $5.6B | $477M |
| Q3 FY2025 | $3.35 | $6.4B | $833M |
| Q2 FY2025 | $3.00 | $6.3B | $755M |
The Sherwin-Williams Company (SHW) reports in 92 days, with the next report estimated for September 13, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 3.8% on average — the market has been roughly fair on SHW's earnings risk. Fundamentals into the print: EPS up 7.5% year-over-year, revenue up 6.8%. QuantLogix's live 5-factor engine currently reads SHW as a buy at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →